These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 13971519)
1. [Results of treatment with complamine in ulcus cruris, thrombosis and arterial embolism]. BLASCHKE F Med Welt; 1962 Oct; 40():2115-8. PubMed ID: 13971519 [No Abstract] [Full Text] [Related]
2. [COMPLAMINE TREATMENT OF PATIENTS WITH INCREASED SERUM CHOLESTEROL VALUES]. WENNERBY S Sven Lakartidn; 1964 Sep; 61():2642-6. PubMed ID: 14223465 [No Abstract] [Full Text] [Related]
3. [A contribution to the scope of indication for complamine therapy]. KAULBACH J Med Lav; 1961 Apr; 56():721-3. PubMed ID: 15445310 [No Abstract] [Full Text] [Related]
4. [The observation of the influence of the unretarded form of xanthinol-niacinate (Complamine) in ulcus cruris venosum on the skin temperature of the lower extremities with the biochemical determination of the levels of the preparation (author's transl)]. Resl V; Götzová ; Vitous J Cesk Dermatol; 1976 Dec; 51(6):389-93. PubMed ID: 1009598 [No Abstract] [Full Text] [Related]
5. [On the treatment of cerebral sclerosis with complamine]. KESSENS L Med Welt; 1960 Nov; 47():2517-8. PubMed ID: 13752735 [No Abstract] [Full Text] [Related]
6. [Rheographic studies and results of treatment with complamine (A contribution to the therapy of ulcus cruris "varicosum")]. Kresbach H; Willingshofer H Z Haut Geschlechtskr; 1965 Jul; 39(1):14-22. PubMed ID: 5838624 [No Abstract] [Full Text] [Related]
7. [Clinical trial of the treatment of peripheral circulation disorders with Complamine]. SPERLING M Munch Med Wochenschr; 1962 Jul; 104():1273-8. PubMed ID: 13915730 [No Abstract] [Full Text] [Related]
8. [Experiences in the treatment of arterial and venous blood circulation disorders, including ulcus cruris, with a nicotinic acid-xanthine derivative]. EHLERS G Z Haut Geschlechtskr; 1961 Dec; 31():310-22. PubMed ID: 13889481 [No Abstract] [Full Text] [Related]
9. [DERMATOLOGIC EXPERIENCES WITH COMPLAMIN]. WOLKE O Ther Ggw; 1965 Apr; 104():522-31. PubMed ID: 14310700 [No Abstract] [Full Text] [Related]
10. [ON THE TREATMENT OF APOPLEXY WITH COMPLAMIN (7-(2-HYDROXY-3-(N-2-HYDROXYETHYL-N-METHYLAMINO)PROPYL)THEOPHYLLINE NICOTINATE]. FRUHMANN H Med Welt; 1963 Oct; 41():2084-7. PubMed ID: 14134155 [No Abstract] [Full Text] [Related]
11. [TREATMENT OF HYPERCHOLESTEREMIA WITH COMPLAMIN (7-/2-HYDROXY-3-(N-2-HYDROXYETHYL-N-METHYLAMINO)-PROPYLTHEOPHYLLINE NICOTINATE)]. BRANDEL E Z Gesamte Inn Med; 1965 May; 20():283-7. PubMed ID: 14306484 [No Abstract] [Full Text] [Related]
12. [ON THE MODERN THERAPY OF THE VARICOSE SYMPTOM COMPLEX AND POSTTHROMBOTIC SEQUELAE]. BLUME HW Med Welt; 1964 Jan; 2():101-6. PubMed ID: 14127678 [No Abstract] [Full Text] [Related]
15. [ON THE TREATMENT OF CEREBRAL AND PERIPHERAL CIRCULATORY DISORDERS. (REPORT ON CLINICAL EXPERIENCES WITH COMPLAMIN)]. LOOS M Med Welt; 1964 Aug; 32():1710-2. PubMed ID: 14291150 [No Abstract] [Full Text] [Related]
16. [Various trials on the effect of nicotinic acid and Complamin on fibrinolysis]. MOERS AM; den OTTOLANDER GJ Ned Tijdschr Geneeskd; 1962 Jun; 106():1221-5. PubMed ID: 14475011 [No Abstract] [Full Text] [Related]
17. [CLINICO-ELECTROENCEPHALOGRAPHIC FINDINGS IN VASOACTIVE TREATMENT WITH COMPLAMIN]. FLUEGEL KA; MENGI E; CORA R Med Klin; 1964 Nov; 59():1831-5. PubMed ID: 14330837 [No Abstract] [Full Text] [Related]
18. STUDIES WITH COMPLAMIN, A NICOTINIC-ACID-THEOPHYLLINE ESTER, AS A FIBRINOLYTIC AGENT. MCNICOL GP; DOUGLAS AS Br Med J; 1965 May; 1(5443):1149-53. PubMed ID: 14273517 [No Abstract] [Full Text] [Related]
19. [INFLUENCE OF 3-(METHYL-OXYETHYLAMINO)-2OXYPROPYLTHEOPHYLLINE NICOTINATE (COMPLAMIN) ON THE HEALING OF EXPERIMENTAL CUTANEOUS WOUNDS]. MASTROJENI D; CAMBRIA S G Ital Chir; 1963 Sep; 19():599-605. PubMed ID: 14130559 [No Abstract] [Full Text] [Related]
20. [On the treatment of dermatological disease pictures with Complamin]. KLEINHANS H Med Klin; 1962 Feb; 57():239-40. PubMed ID: 14456820 [No Abstract] [Full Text] [Related] [Next] [New Search]